LEADER 01586nam  22004213  450 
001 9910867451803321
005 20250905110031.0
010   $a9781529236750
035   $a(CKB)32646839700041
035   $a(MiAaPQ)EBC31324046
035   $a(Au-PeEL)EBL31324046
035   $a(DE-B1597)666529
035   $a(DE-B1597)9781529236750
035   $a(ODN)ODN0012050829
035   $a(EXLCZ)9932646839700041
100   $a20240708d2024      uy         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiomedical Innovation in Fertility Care $eEvidence Challenges, Commercialization, and the Market for Hope
205   $a1st ed.
210  1$aBristol :$cBristol University Press,$d2024.
210  4$dİ2024.
215   $a1 online resource (197 pages)
311 08$a9781529236743 
330   $aAvailable Open Access digitally under CC-BY-NC-ND licence. This book analyses the clashes between evidence-based medicine and the dynamics of an increasingly privatised fertility care industry. With a unique focus on add-on treatments, it reveals how these controversial treatments are now widespread and can border on hopemongering.
606   $aSOCIAL SCIENCE / Technology Studies$2bisacsh
615  7$aSOCIAL SCIENCE / Technology Studies.
676   $a174.2
700   $aPerrotta$b Manuela$01743604
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910867451803321
996   $aBiomedical Innovation in Fertility Care$94171814
997   $aUNINA